Perkant Tech Raises INR 6.6 Crore Seed Round Led by YourNest Venture Capital & Govt. Initiatives

Muskaan Kapoor

03 Apr 2025 — 4 min read

Perkant Tech Raises INR 6.6 Crore Seed Round

Perkant Tech, inventors of a leading AI-enabled med-tech Multi-disease Prognostic Health Platform, has raised INR 6.6 Crore in a seed funding round led by YourNest Venture Capital. This round includes contributions of INR 5 crore from YourNest, INR 1 crore from the Government of India’s Atal New India Challenge (AIM, NITI Aayog), INR 35 lakh from Villgro Foundation, and INR 25 lakh from the accelerator Sanchi Connect, who partnered with YourNest in its Velocity fast-track funding program.

Indore-based Perkant Tech was founded during COVID-19 in 2020 by Lokant Jain and Saniya Jeswani, two young engineers in their final year of college. It offers a medical device with an exclusive suite of AI-augmented health solutions which empowers individuals and healthcare providers with real-time, predictive health insights, ranging from preventative screenings to comprehensive monitoring. This sustainable, upgradable platform redefines healthcare with precision, adaptability and scalability, bridging critical gaps in accessibility and supporting a future of equitable healthcare for all.

This investment will enable Perkant Tech to enhance its AI-powered prognostic technology, accelerate the R&D efforts and support market expansion and customer acquisition strategies as the company gears up for its commercial launch following successful pilots with world-class partners. Additionally, the funds will also be allocated towards technology upgrades and software development to ensure seamless integration, real-time updates, and personalized health insights, preparing the company’s solutions for widespread adoption.

Saniya Jeswani, Co-founder & CEO of Perkant Tech, said, “This investment marks a pivotal step in a journey that began for Lokant and me in our early twenties, driven by a vision to make healthcare truly proactive and universally accessible. With this support, our dedication to advancing prognostic technology reaches new heights. We are fuelled by a passion to deliver predictive health insights that empower individuals everywhere—even in the remotest corners of the world. This isn’t just an investment in technology; it’s a commitment to a future where accessible, life-enhancing healthcare is within reach for all.”

Dr. Vivek Mansingh, General Partner of YourNest, said, “We are excited to back Perkant Tech as they revolutionize healthcare accessibility. Their innovative, AI-powered health screening device addresses a critical need with unmatched scalability and affordability, and we are confident in their ability to drive significant impact and growth in the healthcare sector.”

Perkant Tech holds a granted Indian patent (Application: 526020) and a pending U.S. patent (Application: 18/033,887) for an advanced apparatus designed to measure and acquire distress data from the human body, encompassing both psychological and physiological indicators. Aligned with the government’s National Digital Health Mission (NDHM), Perkant Tech’s integrated platform of measures tracks and analyzes essential health vitals, redefining primary and preventive care delivery across rural and urban deployments. At the heart of this suite is Perkant Tech's flagship invention, Abhay Parimiti—patented in India and the US—which provides automated health assessments in under 60 seconds, making healthcare insights accessible, rapid and impactful.

Perkant Tech’s system serves as a digital doctor for India, powered by patented AI-driven multi-disease prognostic technology, bridging healthcare gaps in underserved regions where medical infrastructure and personnel are scarce. The key focus areas include advancing product research and development to maximise the capabilities of its health monitoring systems. The startup aims to expand beyond core metrics such as cardiac and respiratory health, delving into specific disease detection, early onset identification and recovery tracking. Its vision is to develop technology that serves as an early-stage indicator for conditions traditionally requiring invasive testing, pushing the boundaries of non-invasive health monitoring.

About Perkant Tech

Founded by two visionary engineers in their final year of engineering, Perkant Tech emerged from a mission to revolutionise healthcare through technical expertise and the founders’ innovative perspective. Today, Perkant Tech has evolved into a pioneering medical device company with an exclusive suite of AI-augmented health solutions engineered to deliver precision-driven healthcare even in the most resource-constrained settings. Recognised among the top 50 healthcare startups by AIM, NITI Aayog and acclaimed by global entities such as WHO (World Health Organization), Perkant Tech has quickly distinguished itself as a high-impact startup.

Its health suite is engineered to disrupt conventional health screening, monitoring and surveillance paradigms, ushering in a transformative approach to cardiac, respiratory, and comprehensive health assessment. Anchored by internationally patented technology, this suite integrates an advanced health monitoring system capable of capturing over 700 biomarkers for high-accuracy, early-stage disease risk assessment. Alongside this, an IoT-integrated interface offers seamless operability, democratising health data and delivering contextualised health insights. This unified hardware-software ecosystem leverages high resolution biomarker analytics with predictive AI, establishing a cutting-edge early-alert system for cardiac, respiratory and general health conditions. Through proprietary algorithms and patented methodologies, Perkant Tech is redefining health screening and monitoring with a robust, scalable, AI-powered prognostic platform for multi-disease risk prediction

About YourNest

YourNest, established in 2011 as a technology-focused Pre-Series A fund house, has pioneered investing in DeepTech and IP-led product innovations. Focused on emerging technologies to enhance the way mankind leverages the value of time, YourNest Innovative Products VC Fund III aims to create an opportunity for Indian entrepreneurs to scale into global markets. Many of YourNest’s portfolio companies across its three funds have secured patents and attracted Fortune 500 Companies as customers. In its first Fund, YourNest has provided a DPI of 1.9x with five complete exits and one partial exit. Its second Fund is fully invested with one full exit and two partial exits. YourNest’s funds consistently feature amongst the best-performing AIFs as per the CRISIL AIF Performance Reports.

About Sanchi Connect

Sanchi Connect is a leading accelerator and community for DeepTech startups, investors, mentors and key stakeholders. Backed by Baring PE partners and prominent VCs and headquartered in Noida, the company has invested in IP-led pre-seed startups earlier through its thematic accelerator cohorts, and also serves multiple corporates in managing their startup-centric programs and open innovation needs.